These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 2338501)
1. Development of a new culture system for human lymphokine-activated killer cells. Murata M; Yano T; Togami M; Yasumoto K; Sugimachi K; Kimura G; Nomoto K J Immunol Methods; 1990 May; 129(1):89-95. PubMed ID: 2338501 [TBL] [Abstract][Full Text] [Related]
2. Development of a new culture system for human lymphokine-activated killer cells: comparison with a conventional static culture method. Murata M; Yano T; Yoshino I; Togami M; Sogabe M; Yasumoto K; Sugimachi K; Kimura G; Nomoto K Cytotechnology; 1991 Oct; 7(2):75-83. PubMed ID: 1367909 [TBL] [Abstract][Full Text] [Related]
3. [Induction of LAK cells by high density dialyzing culture device and its cytotoxicity]. Kohgo Y; Kanisawa Y; Sakamaki S; Nojiri S; Ueno Y; Ito Y; Niitsu Y; Hosoi S; Sato S; Urushizaki I Hum Cell; 1988 Mar; 1(1):54-9. PubMed ID: 3154014 [TBL] [Abstract][Full Text] [Related]
4. A high density cell culture system for generation of human lymphokine-activated killer (LAK) cells for clinical use in adoptive immunotherapy. Shimizu K; Park K; Yamada M; Tarura K; Matsui Y; Hayakawa T J Clin Lab Immunol; 1990 May; 32(1):41-7. PubMed ID: 1967036 [TBL] [Abstract][Full Text] [Related]
5. Studies of serum-free medium for the generation of lymphokine-activated killer cells. Togami M; Yasumoto K; Yano T; Ishida T; Kimura G; Sugimachi K; Nomoto K Cytotechnology; 1991 May; 6(1):39-47. PubMed ID: 1367399 [TBL] [Abstract][Full Text] [Related]
6. Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood. Alderson MR; Sassenfeld HM; Widmer MB J Exp Med; 1990 Aug; 172(2):577-87. PubMed ID: 2142722 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneity in lectin-binding characteristics of human lymphokine-activated killer cells. Maruyama T; Imai Y; Harada K; Okada T; Takano M; Ikeda Y; Toda G; Oka H; Osawa T J Biol Response Mod; 1990 Aug; 9(4):378-86. PubMed ID: 2395003 [TBL] [Abstract][Full Text] [Related]
8. Expansion of lymphokine-activated killer cells for clinical use utilizing a novel culture device. Colborn D; Rinehart J; Zwilling B; Irr J J Immunol Methods; 1989 May; 119(2):247-54. PubMed ID: 2786037 [TBL] [Abstract][Full Text] [Related]
9. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues. Colquhoun SD; Economou JS; Shau H; Golub SH J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-2 modulates the expression of lymphocyte function-associated antigen-one (LFA-1) and p150,95 during the generation of lymphokine-activated killer (LAK) cells. Grant AJ; Merchant RE; Hall RE Immunology; 1989 Jan; 66(1):117-24. PubMed ID: 15493273 [TBL] [Abstract][Full Text] [Related]
11. Gelatin sponge model of effector recruitment: tumoricidal activity of adherent and non-adherent lymphokine-activated killer cells after culture in interleukin-2. Akporiaye ET; Barbieri CA; Stewart CC; Bender JG J Leukoc Biol; 1991 Feb; 49(2):189-96. PubMed ID: 1991999 [TBL] [Abstract][Full Text] [Related]
12. Lymphokine-activated killer cells: culture conditions for the generation of maximal in vitro cytotoxicity in cells from normal donors. Beckner SK; Maluish AE; Longo DL Cancer Res; 1987 Oct; 47(20):5504-8. PubMed ID: 3498534 [TBL] [Abstract][Full Text] [Related]
13. Lymphokine-activated killer (LAK) cell generation from peripheral blood stem cells by in vitro incubation with low-dose interleukin-2 plus granulocyte-macrophage colony-stimulating factor. Herrera C; García-Pérez MJ; Ramirez R; Martín C; Alvarez MA; Martinez F; Gómez P; García-Castellano JM; Torres A Bone Marrow Transplant; 1997 Mar; 19(6):545-51. PubMed ID: 9085733 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity against autologous, allogeneic, and xenogeneic tumor targets by human recombinant interleukin-2-activated lymphocytes from healthy dogs and dogs with lung tumors. Mitchell DH; Withrow SJ; Johnston MR; Kruse CA Am J Vet Res; 1991 Jul; 52(7):1132-6. PubMed ID: 1892269 [TBL] [Abstract][Full Text] [Related]
15. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts. Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628 [TBL] [Abstract][Full Text] [Related]
16. Effect of anti-CD3 antibody on the generation of interleukin-2-activated lymphocytes from tumor tissues of gastrointestinal cancer. Ohta T; Kikuchi H; Ogata H; Iwata K; Yoshida K; Katayama K; Watanabe H Cancer; 1992 Aug; 70(4):741-8. PubMed ID: 1386555 [TBL] [Abstract][Full Text] [Related]
17. Enhanced human lymphokine-activated killer cell function after brief exposure to granulocyte-macrophage-colony stimulating factor. Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Beroukas C; Stathopoulos GP; Papamichail M Cancer; 1995 Oct; 76(7):1253-60. PubMed ID: 8630906 [TBL] [Abstract][Full Text] [Related]
18. T cells and monocytes regulate the generation and functional activity of natural killer-derived lymphokine-activated killer cells. Atzpodien J; Gulati SC Stem Cells; 1993 Nov; 11(6):511-8. PubMed ID: 8111310 [TBL] [Abstract][Full Text] [Related]
19. Sequential TNF and TGF-beta regulation of expansion and induction of cytotoxicity in long-term cultures of lymphokine-activated killer cells. Koberda J; Przepiorka D; Moser RP; Grimm EE Lymphokine Cytokine Res; 1994 Apr; 13(2):139-45. PubMed ID: 8061115 [TBL] [Abstract][Full Text] [Related]
20. Long-term cultures of human peripheral blood lymphocytes with recombinant human interleukin-2 generate a population of virtually pure CD3+ CD16- CD56- large granular lymphocyte LAK cells. Roussel E; Gerrard JM; Greenberg AH Clin Exp Immunol; 1990 Nov; 82(2):416-21. PubMed ID: 1700746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]